Drug Profile


Alternative Names: BRL 34915; Chromakalim

Latest Information Update: 16 Dec 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antiallergics; Antiarrhythmics; Antiasthmatics; Antihypertensives; Benzopyrans; Pyrroles; Small molecules
  • Mechanism of Action KATP channel stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias; Asthma; Cardiomyopathies; Hypertension; Ischaemic heart disorders; Peptic ulcer

Most Recent Events

  • 16 Dec 1999 Discontinued-Preclinical for Cardiomyopathy in Canada (Unknown route)
  • 16 Dec 1999 Discontinued-Preclinical for Peptic ulcer in India (Unknown route)
  • 28 Sep 1998 No-Development-Reported for Cardiomyopathy in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top